Subclinical thyroid dysfunction

被引:67
作者
Woeber, KA
机构
[1] Department of Medicine, University of California, S. Francisco Mt. Zion Medical Center
[2] University of California, S. Francisco Mt. Zion Medical Center, Box 1640, San Francisco
关键词
D O I
10.1001/archinte.157.10.1065
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Subclinical thyroid dysfunction may be defined as an abnormal serum thyrotropin concentration in an asymptomatic patient with a normal serum free thyroxine concentration, This article addresses the prevalence, natural history, and potential pathophysiological consequences of subclinical hypothyroidism and subclinical thyrotoxicosis, Subclinical hypothyroidism, which occurs in more than 10% of women older than 60 years, may be accompanied by an unfavorable serum lipid profile and may lower the threshold for the development of major depressive disorder. Subclinical thyrotoxicosis, which is most commonly due to thyrotropin-suppressive levothyroxine sodium therapy, may be associated with reduced bone mineral density in postmenopausal women and confers a 3-fold relative risk for the development of atrial fibrillation. While there are no outcome data to support therapeutic intervention in subclinical thyroid dysfunction, some screening and management recommendations are offered.
引用
收藏
页码:1065 / 1068
页数:4
相关论文
共 38 条
[1]   LIPOPROTEIN AND APOLIPOPROTEIN LEVELS IN SUBCLINICAL HYPOTHYROIDISM - EFFECT OF LEVOTHYROXINE THERAPY [J].
AREM, R ;
PATSCH, W .
ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (10) :2097-2100
[2]   THYROID-DYSFUNCTION IN ADULTS OVER AGE 55 YEARS - A STUDY IN AN URBAN UNITED-STATES COMMUNITY [J].
BAGCHI, N ;
BROWN, TR ;
PARISH, RF .
ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (04) :785-787
[3]   CONTROL OF ADRENERGIC OVERACTIVITY BY BETA-BLOCKADE IMPROVES THE QUALITY-OF-LIFE IN PATIENTS RECEIVING LONG-TERM SUPPRESSIVE THERAPY WITH LEVOTHYROXINE [J].
BIONDI, B ;
FAZIO, S ;
CARELLA, C ;
SABATINI, D ;
AMATO, G ;
CITTADINI, A ;
BELLASTELLA, A ;
LOMBARDI, G ;
SACCA, L .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (05) :1028-1033
[4]   CARDIAC EFFECTS OF LONG-TERM THYROTROPIN-SUPPRESSIVE THERAPY WITH LEVOTHYROXINE [J].
BIONDI, B ;
FAZIO, S ;
CARELLA, C ;
AMATO, G ;
CITTADINI, A ;
LUPOLI, G ;
SACCA, L ;
BELLASTELLA, A ;
LOMBARDI, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (02) :334-338
[5]   SUBCLINICAL HYPOTHYROIDISM AND HYPERLIPOPROTEINEMIA - INDISCRIMINATE L-THYROXINE TREATMENT NOT JUSTIFIED [J].
BOGNER, U ;
ARNTZ, HR ;
PETERS, H ;
SCHLEUSENER, H .
ACTA ENDOCRINOLOGICA, 1993, 128 (03) :202-206
[6]   DECREASED HDL CHOLESTEROL IN SUBCLINICAL HYPOTHYROIDISM - THE EFFECT OF L-THYROXINE THERAPY [J].
CARON, P ;
CALAZEL, C ;
PARRA, HJ ;
HOFF, M ;
LOUVET, JP .
CLINICAL ENDOCRINOLOGY, 1990, 33 (04) :519-523
[7]   THE EFFECTS OF NONTHYROID DISEASE AND DRUGS ON THYROID-FUNCTION TESTS [J].
CAVALIERI, RR .
MEDICAL CLINICS OF NORTH AMERICA, 1991, 75 (01) :27-39
[8]   SUBCLINICAL HYPOTHYROIDISM RESULTING FROM AUTOIMMUNE-THYROIDITIS IN FEMALE-PATIENTS WITH ENDOGENOUS-DEPRESSION [J].
CUSTRO, N ;
SCAFIDI, V ;
LOBAIDO, R ;
NASTRI, L ;
ABBATE, G ;
CUFFARO, MP ;
GALLO, S ;
VIENNA, G ;
NOTARBARTOLO, A .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1994, 17 (08) :641-646
[9]   PREVALENCE AND CORRECTION OF HYPOTHYROIDISM IN A LARGE COHORT OF PATIENTS REFERRED FOR DYSLIPIDEMIA [J].
DIEKMAN, T ;
LANSBERG, PJ ;
KASTELEIN, JJP ;
WIERSINGA, WM .
ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (14) :1490-1495
[10]   THE RELATIONSHIP BETWEEN SERUM-CHOLESTEROL AND SERUM THYROTROPIN, THYROXINE AND TRI-IODOTHYRONINE CONCENTRATIONS IN SUSPECTED HYPOTHYROIDISM [J].
ELDER, J ;
MCLELLAND, A ;
OREILLY, DS ;
PACKARD, CJ ;
SERIES, JJ ;
SHEPHERD, J .
ANNALS OF CLINICAL BIOCHEMISTRY, 1990, 27 :110-113